4 ms·
Agreed that this process would need to be tailor made for each person, but there are a lot of efforts out there at industrializing and streamlining this process
by epistasis 8y ago
Agreed that this process would need to be tailor made for each person, but there are a lot of efforts out there at industrializing and streamlining this process.
The process itself is extremely difficult with lots of ways that it can go wrong. But as with other areas of molecular biology, there's hope that the consistency of automation may improve that.
Current cancer treatments that are used in practice can easily make it in to tens of thousands per month of treatment. That provides a lot of wiggle room for doing expensive things.
Once there's a reason to produce thousands or millions of individualized cell therapies, it's likely that the process could be made economically feasible.